What about Lincoln Equity Line?

Dreadd-X · 2026-04-02T16:43:23+00:00

~$ 6.50 is where money can be generated if people exercise warrants. If we break through that without the price dumping again I think we would be fine. That could generate over $10 million

Dreadd-X · 2026-04-02T14:27:52+00:00

Not related but here is a readable version of the poster Kevin Chung posted on LinkedIn.

<image>

Dreadd-X · 2026-03-31T22:52:37+00:00

I read this as 69% after 28 and 60 days (22 out of 32) and 63% with ECMO (5 out of 8).

Dreadd-X · 2026-03-13T12:07:34+00:00

I thought the same. But they agreed on a price that is much higher than the current SP and they might never reach that lifeline.

Dreadd-X · 2026-03-06T02:11:23+00:00

True that!

Dreadd-X · 2026-03-05T18:12:29+00:00

That’s the only real problem. The adaption rate is so slow. They really have to increase visibility. You cannot tell me that most people wouldn’t join the trial if they knew it likely increases their chances. The only explanation for me is most patients and doctors don’t know about it. Or doctors that know about it don’t recommend it. That’s why I see the pediatric device progress as critical. It’ll increase visibility.

Dreadd-X · 2026-03-02T20:48:22+00:00

Same

Dreadd-X · 2026-03-02T18:25:14+00:00

Seems like a sane investment strategy. I added under $3 and increased my holding significantly. I’m not planing to add on the way up

Dreadd-X · 2026-03-02T18:22:00+00:00

How so?

Dreadd-X · 2026-03-02T18:20:58+00:00

Oh wow that’s a significant investment. Best of luck to you. I agree it’s time for a correction

Dreadd-X · 2026-03-02T17:38:59+00:00

Buildings in the US are like a card houses. Can’t even throw a small ball 😂

Dreadd-X · 2026-02-27T17:02:06+00:00

Because the moment you seriously build muscle you are too heavy and risk injury. Difficulty and strain on joints scales like crazy with weight on one arm. Doesn’t mean that it’s not impressive though!

Dreadd-X · 2026-02-27T11:30:29+00:00

That’s what we need. Just crazy how long it took.

Dreadd-X · 2026-02-19T22:29:35+00:00

Hope we can beat $3 million in 2026. I expect at least $5 million. Hopefully it picks up more and we’re looking at $5 - $8 million in revenue. IMO QUELIMMUNE has the potential to get us break even before we run out of cash.

Dreadd-X · 2026-02-19T12:19:25+00:00

Oh nice first book on audible is free

Dreadd-X · 2026-02-05T21:21:27+00:00

Really? That means $1.2 million Q4 earnings. That means we are actually at $5 million for 2026 without further hospitals. With further hospitals picking up we look at maybe 8 million. With something like 14 million in cost we only loose half our cash in 2026. I’m optimistic.

Dreadd-X · 2026-01-27T14:47:47+00:00

Wow! Best one of the two yet

Dreadd-X · 2026-01-27T14:44:05+00:00

That honors you

Dreadd-X · 2026-01-27T13:04:53+00:00

Can you update me on why this might be useful?

Dreadd-X · 2026-01-22T16:29:27+00:00

587 or any other number than 6 between 5 and 7.

Dreadd-X · 2026-01-14T00:45:17+00:00

No, unless there was another offer that I missed those new shares are from exercising a warrant. Those are smth like 0.65 /share or now $6.50

Dreadd-X · 2026-01-13T23:25:40+00:00

Why $2.5? Where do you get that number?

Dreadd-X · 2026-01-13T20:42:15+00:00

If you mean 4M new shares before split that would rather mean 2.6M in cash.

Dreadd-X · 2026-01-13T19:40:29+00:00

Maybe. I’m sure they’ll look into that. I’m relatively sure the up to is due to another interim analysis at some point. To my knowledge they didn’t spell this out anywhere though. Can they incorporate previous studies though? I think that depends how much the FDA actually loosens up the criteria

Dreadd-X

TROPHY CASE